Bvf Inc Surface Oncology, Inc. Transaction History

Bvf Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$5.06 - $7.23 $10.3 Million - $14.7 Million	-2,038,528 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.57 - $6.56 $1.66 Million - $6.92 Million	1,055,477 Added 107.37%	2,038,528 $13.4 Million
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $148,608 - $407,640	-103,200 Reduced 9.5%	983,051 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$1.4 - $2.84 $91,023 - $184,648	65,017 Added 6.37%	1,086,251 $1.54 Million
Q2 2019 Aug 14, 2019	BUY	$2.75 - $4.89 $1.57 Million - $2.78 Million	569,384 Added 126.01%	1,021,234 $2.88 Million
Q4 2018 Feb 14, 2019	BUY	$3.65 - $10.69 $334,456 - $979,546	91,632 Added 25.44%	451,850 $1.92 Million
Q3 2018 Nov 14, 2018	BUY	$8.92 - $17.83 $230,894 - $461,529	25,885 Added 7.74%	360,218 $3.94 Million
Q2 2018 Aug 14, 2018	BUY	$12.83 - $17.41 $4.29 Million - $5.82 Million	334,333 New	334,333 $5.45 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.